| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |